HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Permissions Request Permissions Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Costabel, U. Search for Related Content PubMed PubMed Citation Articles by Costabel, U.

Sarcoidosis: clinical update

CORRESPONDENCE: U. Costabel, Ruhrlandklinik, Dept Pneumology/Allergology, Tueschener Weg 40, 45239, Essen, Germany. Fax: 49 2014334029

Keywords: bronchoalveolar lavage, CD4/CD8 ratio, corticosteroids, Löfgren's syndrome, sarcoidosis

Received: March 8, 2001
Many advances have been made regarding sarcoidosis in the past 2 decades. As a result, sarcoidosis is now defined as a multisystem disorder with a heightened cellular immune response at sites of disease activity in patients with a predisposition for sarcoidosis and a presumed exposure to as yet unknown transmissible environmental agents.

Recent International Consensus Statement recommendations regarding diagnosis and therapy have been published. The diagnosis of sarcoidosis is based on a compatible clinical and/or radiological picture, histological evidence of noncaseating granulomas and exclusion of other diseases capable of producing a similar histological or clinical picture.

Therapy is based on corticosteroids, although there are indications of valuable alternatives. Except for life- and sight-threatening organ involvement, it should be carefully considered whether the patient might benefit from treatment. For asymptomatic pulmonary sarcoidosis, a watch and wait approach is appropriate; treatment should mainly be considered if symptoms develop or lung function deteriorates.

This article has been cited by other articles:

				G. Paone, G. Lucantoni, A. Leone, P. Graziano, R. Gasbarra, G. Galluccio, S. D'Antoni, G. Puglisi, E. Girardi, and G. Schmid Human Neutrophil Peptides Stimulate Tumor Necrosis Factor-{alpha} Release by Alveolar Macrophages From Patients With Sarcoidosis Chest, February 1, 2009; 135(2): 586 - 587. [Full Text] [PDF]

				B. J. Plant, S. Ghani, M. J. O'Mahony, L. Morgan, C. M. O'Connor, K. Morgan, J. A. Baugh, and S. C. Donnelly Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population Eur. Respir. J., February 1, 2007; 29(2): 325 - 329. [Abstract] [Full Text] [PDF]